Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

4.810 -0.780 (-13.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (... 
Via Benzinga
15 Stocks Moving in Tuesday's Pre-Market Session
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted... 
Via Benzinga
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... 
Via Benzinga
Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
From Quanterix Corporation
Via Business Wire
FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label
The FDA has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's (NASDAQ: QTRX) Simoa SARS-CoV-2 N Protein Antigen Test. The... 
Via Benzinga
Exposures COVID-19 Product Safety
Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
From Quanterix Corporation
Via Business Wire
Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”
From Quanterix Corporation
Via Business Wire
Return On Capital Employed Insights For Quanterix
Benzinga Pro data, Quanterix (NASDAQ:QTRX) reported Q2 sales of $25.37 million. Earnings fell to a loss of $13.67 million, resulting in a 39.63% decrease from last quarter. In Q1... 
Via Benzinga
Why Cassava Sciences Is Plunging Again Today
More red flags are emerging for this troubled Alzheimer's biotech company. 
Via The Motley Fool
Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations
The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again. 
Via Investor's Business Daily
Why Cassava Sciences Stock Investors Are Pulling Back
The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of... 
Via Benzinga
Quanterix Releases Statement
From Quanterix Corporation
Via Business Wire
63 Biggest Movers From Yesterday
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11... 
Via Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,... 
Via Benzinga
Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
From Quanterix Corporation
Via Business Wire
Quanterix Corporation Releases Operating Results for Second Quarter of 2021
From Quanterix Corporation
Via Business Wire
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
From Quanterix Corporation
Via Business Wire
Quanterix Appoints Michael Doyle as Chief Financial Officer
From Quanterix Corporation
Via Business Wire
Medical Device Maker Quanterix Stock Shows Rising Relative Strength
On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before. 
Via Investor's Business Daily
Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis
From Quanterix Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021
Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high... 
Via Benzinga
Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report
From Quanterix Corporation
Via Business Wire
Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics
From Quanterix Corporation
Via Business Wire
64 Biggest Movers From Yesterday
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
Quanterix Corporation Releases Operating Results for First Quarter 2021
From Quanterix Corporation
Via Business Wire
Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021
From Quanterix Corporation
Via Business Wire
Quanterix Appoints Laurie Olson to Board of Directors
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.